Full range of Regulatory Toxicology services at your disposal
For over 40 years Scantox has been a preferred supplier of in vivo services to the pharma and biotech industries in Europe. From our facilities in Scandinavia we offer studies in all main species and duirng the study you are in direct contact with our experienced scientists.
Rapid study starts 4 to 6 weeks from contract execution
On-time reporting with an Audited Draft just 8-10 weeks from end of in-life.
Why Scantox as your CRO for Regulatory Tox studies?
- IND enabling capabilities
- All standard routes of administration
- Dose preparation and dose formulation analysis is performed onsite
- Histology and pathology is performed in-house
- Safety Pharmacology Core battery – Rat Respiratory, Cardiovascular via implantable telemetry device or jacketed telemetry
- Juvenile and Repro tox studies Segment 1 & 2
- Small and large animal surgery onsite
- SEND compliant
- Best in Class “Animal Welfare” Program
- Rapid study starts – 4 to 6 weeks from contract execution
- On-time reporting – Audited Draft 8 to 10 weeks from end of in-life